Different domains of the ORL1 and κ-opioid receptors are involved in recognition of nociception and dynorphin A

FEBS Letters

Volumn 427, Issue 2, 1998, Pages 296-300

  Lapalu, Sophie ^a   Moisand, Christiane ^a   Butour, Jean Luc ^a   Mollereau, Catherine ^a   Meunier, Jean Claude ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

Gain of function protein engineering; Non opioid opioid hybrid receptor; Opioid peptide; Structure function relationship

Indexed keywords

COMPLEMENTARY DNA; KAPPA OPIATE RECEPTOR; NOCICEPTIN; OPIATE PEPTIDE;

ANIMAL CELL; ARTICLE; CHIMERA; CHO CELL; CONTROLLED STUDY; GENETIC ENGINEERING; HUMAN; HYBRID; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY;

ANIMALS; CHO CELLS; CRICETINAE; CYCLIC AMP; DYNORPHINS; FORSKOLIN; HUMANS; KINETICS; LIGANDS; NARCOTIC ANTAGONISTS; NARCOTICS; OPIOID PEPTIDES; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, OPIOID; RECEPTORS, OPIOID, KAPPA; RECOMBINANT FUSION PROTEINS;

ANIMALIA;

EID: 0032496406     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)00452-9     Document Type: Article

References (26)

1. Mollereau C., Parmentier M., Mailleux P., Butour J.-L., Moisand Ch., Chalon P., Caput D., Vassart G., Meunier J.-Cl. FEBS Lett. 341:1994;33-38.
2. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H., Iwabe N., Miyata T., Houtani T., Sugimoto T. FEBS Lett. 343:1994;42-46.
3. Chen Y., Fan Y., Liu J., Mestek A., Tian M., Kozak C.A., Yu L. FEBS Lett. 347:1994;279-283.
4. Bunzow J.R., Saez C., Mortrud M., Bouvier C., Williams J.T., Low M., Grandy D.K. FEBS Lett. 347:1994;284-288.
5. Wang J.B., Johnson P.S., Imai Y., Persico A.M., Ozenberger B.A., Eppler C.M., Uhl G.R. FEBS Lett. 348:1994;75-79.
6. Nishi M., Takeshima H., Mori M., Nakagawara K.I., Takeuchi T. Biochem. Biophys. Res. Commun. 205:1994;1353-1357.
7. Lachowicz J.E., Shen Y., Monsma F.J., Sibley D.R. J. Neurochem. 64:1995;34-40.
8. Wick M.J., Minnerath S.R., Roy S., Ramakrishnan S., Loh H.H. Mol. Brain Res. 32:1995;342-347.
9. Meunier J.Cl., Mollereau C., Toll L., Suaudeau Ch., Moisand Ch., Alvinerie P., Butour J.L., Guillemot J.Cl., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., Costentin J. Nature. 377:1995;532-535.
10. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J., Civelli O. Science. 270:1995;792-794.
11. Chen C., Okayama H. Mol. Cell. Biol. 7:1987;2745-2752.
12. Lowry O.H., Rosebrough A.L., Farr A.L., Randall R.J. J. Biol. Chem. 193:1951;265-275.
13. Alvarez R., Daniels D.V. Anal. Biochem. 203:1992;76-82.
14. Meng F., Hoversten M.T., Thompson R.C., Taylor L., Watson S.J., Akil H. J. Biol. Chem. 270:1995;12730-12736.
15. Kieffer B. Cell. Mol. Neurobiol. 15:1995;615-635.
16. Metzger T.G., Ferguson D.M. FEBS Lett. 375:1995;1-4.
17. Xue J.-C., Chen C., Zhu J., Kunapuli S., DeRiel J.K., Yu L., Liu-Chen L.-Y. J. Biol. Chem. 269:1994;30195-30199.
18. Siciliano S.J., Rollins T.E., DeMartino J., Konteatis Z., Malkowitz L., Van Riper G., Bondy S., Rosen H., Springer M.S. Proc. Natl. Acad. Sci. USA. 91:1994;1214-1218.
19. Stroop S.D., Kuestner R.E., Serwold T.F., Chen L., Moore E.E. Biochemistry. 34:1995;1050-1057.
20. Chavkin C., Goldstein A. Proc. Natl. Acad. Sci. USA. 78:1981;6543-6547.
21. Dooley C.T., Houghten R.A. Life Sci. 59:1996;23-29.
22. Reinscheid R.K., Ardati A., Monsma F.J. Jr., Civelli O. J. Biol. Chem. 271:1996;14163-14168.
23. Butour J.-L., Moisand C., Mazarguil H., Mollereau C., Meunier J.-Cl. Eur. J. Pharmacol. 321:1997;97-103.
24. Guerrini R., Caló G., Rizzi A., Bianchi C., Lazarus L.H., Salvadori S., Temussi P.A., Regoli D. J. Med. Chem. 40:1997;1789-1793.
25. Lapalu S., Moisand C., Mazarguil H., Cambois G., Mollereau C., Meunier J.-C. FEBS Lett. 417:1997;333-336.
26. Cheng Y.-C., Prussof W.H. Biochem. Pharmacol. 22:1973;3099-3108.